MNOV (STOCKS)
Medicinova, Inc.
$1.440000
-0.050000 (-3.36%)
Prev close: $1.490000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Yuichi Iwaki
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $70.88M
- Employees
- 6
- P/E (TTM)
- -5.89
- P/B (TTM)
- 1.76
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.05 | $-0.10 | +0.0469 | +48.40% |
|
Sep 2025 (Q3)
|
$-0.06 | $-0.10 | +0.0420 | +41.18% |
|
Jun 2025 (Q2)
|
$-0.07 | $-0.10 | +0.0269 | +27.76% |
|
Mar 2025 (Q1)
|
$-0.06 | $-0.14 | +0.0828 | +57.98% |
Financial Statements
| Revenues | $409.66K |
| Benefits Costs and Expenses | $12.40M |
| Costs And Expenses | $12.40M |
| Operating Expenses | $13.69M |
| Research and Development | $6.70M |
| Other Operating Expenses | $6.99M |
| Operating Income/Loss | -$13.28M |
| Income/Loss From Continuing Operations After Tax | -$12.00M |
| Income/Loss From Continuing Operations Before Tax | -$11.99M |
| Income Tax Expense/Benefit | $5.99K |
| Income Tax Expense/Benefit, Current | $5.99K |
| Net Income/Loss | -$12.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$12.00M |
| Net Income/Loss Available To Common Stockholders, Basic | -$12.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.24 |
| Diluted Earnings Per Share | -$0.24 |
| Basic Average Shares | 49,063,438 |
| Diluted Average Shares | 49,063,438 |
| Assets | $45.60M |
| Current Assets | $30.99M |
| Noncurrent Assets | $14.61M |
| Fixed Assets | $8.34K |
| Other Non-current Assets | $14.60M |
| Liabilities | $4.02M |
| Current Liabilities | $3.80M |
| Accounts Payable | $625.00K |
| Wages | $824.53K |
| Other Current Liabilities | $2.35M |
| Noncurrent Liabilities | $218.92K |
| Equity | $41.59M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $41.59M |
| Liabilities And Equity | $45.60M |
| Net Cash Flow From Operating Activities | -$9.81M |
| Net Cash Flow From Operating Activities, Continuing | -$9.81M |
| Net Cash Flow From Investing Activities | -$2.90K |
| Net Cash Flow From Investing Activities, Continuing | -$2.90K |
| Net Cash Flow From Financing Activities | $244.02K |
| Net Cash Flow From Financing Activities, Continuing | $244.02K |
| Net Cash Flow | -$9.57M |
| Net Cash Flow, Continuing | -$9.57M |
| Comprehensive Income/Loss | -$11.99M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$11.99M |
| Other Comprehensive Income/Loss | $7.97K |